H.R. 4439 · 116th Congress

Creating Hope Reauthorization Act

Stage
Passed a chamber
Introduced
2019-09-20
Latest action
2020-09-30 · Received in the Senate.

Summary

Creating Hope Reauthorization Act

This bill reauthorizes a Food and Drug Administration (FDA) program that awards priority review vouchers to manufacturers of drugs that treat rare pediatric diseases. (A priority review voucher entitles the voucher holder to priority review of a single human drug application.)

Specifically, the bill reauthorizes the program through FY2024, but the FDA may award a voucher afterwards in certain instances.